<PAGE> 1
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------------------
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of December 1999.
AMDOCS LIMITED
Tower Hill House Le Bordage GY1 3QT
St. Peter Port, Island Of Guernsey, Channel Islands
Amdocs, Inc.
1390 Timberlake Manor Parkway, Chesterfield, Missouri, 63017
(Address of principal executive offices)
(Indicate by check mark whether the registrant files or will file annual reports
under cover of Form 20-F or Form 40-F.)
FORM 20-F X FORM 40-F
(Indicate by check mark whether the registrant by furnishing the information
contained in this form is also thereby furnishing the information to the
Commission pursuant to rule 12g3-2 (b) under the Securities Exchange Act of
1934.)
Yes No X
- --------------------------------------------------------------------------------
<PAGE> 2
AMDOCS LIMITED
[AMDOCS LIMITED LOGO]
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
January 26, 2000
To the Shareholders:
The annual General Meeting of shareholders of Amdocs Limited ("Amdocs")
will be held at 10:00 A.M., local time, on Wednesday, January 26, 2000, at the
Drake Swissotel New York, 440 Park Avenue, New York, New York 10022, for the
following purposes:
1. To elect eleven (11) directors for a one-year term until the next
annual general meeting of shareholders or until their respective
successors are elected and qualified or their positions are vacated by
resignation or otherwise.
2. To approve our Consolidated Financial Statements for the fiscal year
ended September 30, 1999.
3. To approve Ernst & Young LLP as our independent auditors for the fiscal
year ending September 30, 2000, and until the next annual general
meeting, and to authorize the board of directors to fix the
remuneration of such auditors in accordance with the extent and nature
of their services.
4. To approve an amendment to our 1998 Stock Option and Incentive Plan, as
amended (the "1998 Plan") to increase the number of ordinary shares
available for grants of options and/or awards under the 1998 Plan.
5. To transact such other business as may properly come before the General
Meeting.
Our board of directors has fixed the close of business on December 1, 1999
as the record date for the determination of our shareholders entitled to notice
of, and to vote on the matters proposed at, the General Meeting and any
adjournments thereof.
YOUR VOTE IS IMPORTANT
ALL HOLDERS OF AMDOCS' VOTING ORDINARY SHARES (WHETHER THEY EXPECT TO
ATTEND THE GENERAL MEETING OR NOT) ARE REQUESTED TO COMPLETE, SIGN, DATE AND
RETURN PROMPTLY THE PROXY CARD ENCLOSED WITH THIS NOTICE. IF YOU EXECUTE A
PROXY, YOU STILL MAY ATTEND THE GENERAL MEETING AND VOTE IN PERSON.
By Order of the Board of Directors
/S/ Thomas G. O'Brien
Thomas G. O'Brien
Secretary
December 15, 1999
------------------------
A proxy card and the Annual Report for
the fiscal year ended September 30, 1999 are enclosed.
<PAGE> 3
AMDOCS LIMITED
PROXY STATEMENT
ANNUAL GENERAL MEETING OF SHAREHOLDERS
JANUARY 26, 2000
References in this Proxy Statement to "Amdocs", "we", "our", "us" and the
"Company" refer to Amdocs Limited and its consolidated subsidiaries and their
respective predecessors.
This Proxy Statement and the accompanying proxy are being furnished to
shareholders of Amdocs Limited, a corporation organized under the laws of the
Island of Guernsey, in connection with the solicitation by its board of
directors of proxies from holders of its outstanding voting ordinary shares, par
value L0.01 per share, ("Ordinary Shares") for use at the annual general meeting
of shareholders to be held at 10:00 A.M., local time, on Wednesday, January 26,
2000, at the Drake Swissotel New York, 440 Park Avenue, New York, New York
10022, or at any adjournments thereof (the "General Meeting"). This Proxy
Statement and the accompanying proxy, together with a copy of our Annual Report
to shareholders, are first being mailed or delivered to our shareholders on or
about December 20, 1999.
At the General Meeting, our shareholders as of the close of business on
December 1, 1999 (the "Record Date") will be asked to vote upon the following:
(i) election of eleven (11) directors for a term of one year until the next
annual general meeting of shareholders and until their respective successors are
elected and qualified or their positions are vacated by resignation or otherwise
(Proposal I); (ii) approval of our Consolidated Financial Statements for the
fiscal year ended September 30, 1999 (Proposal II); (iii) approval of Ernst &
Young LLP as our independent auditors for the fiscal year ending September 30,
2000, and until the next annual general meeting, and authorization of the board
of directors to fix the remuneration of such auditors in accordance with the
extent and nature of their services (Proposal III); and (iv) approval of an
amendment to our 1998 Stock Option and Incentive Plan, as amended (the "1998
Plan") to increase the number of Ordinary Shares available for grants of options
and/ or awards under the 1998 Plan (Proposal IV).
The enclosed proxy confers discretionary authority with respect to any
amendments or modifications of proposals that properly may be brought before the
General Meeting. As of the date hereof, we are not aware of any such amendments
or modifications or other matters to be presented for action at the General
Meeting. However, if any other matters properly come before the General Meeting,
the proxies solicited hereby will be exercised on such matters in accordance
with the reasonable judgment of the proxyholders.
As of the Record Date, Amdocs had outstanding 181,040,634 Ordinary Shares
and 24,210,073 non-voting ordinary shares, par value L0.01 per share
("non-voting Ordinary Shares"). Each Ordinary Share is entitled to one vote on
all matters presented at the General Meeting. Only shareholders of record at the
close of business on the Record Date are entitled to notice of and to vote at
the General Meeting. Votes cast in person or by proxy at the General Meeting
will be tabulated by the inspector of elections appointed for the General
Meeting who will also determine whether a quorum is present for the transaction
of business. The holders of a majority of the outstanding Ordinary Shares
entitled to vote at the General Meeting constitutes a quorum for purposes of the
General Meeting.
Approval of Proposal I to elect eleven (11) directors, Proposal II to
approve our Consolidated Financial Statements, Proposal III to approve Ernst &
Young LLP as our independent auditors and to authorize our board of directors to
fix such auditor's remuneration, and Proposal IV to amend the 1998 Plan require
in each case the affirmative vote of a majority of the Ordinary Shares
represented in person or by proxy at the General Meeting.
The enclosed proxy provides that each shareholder may specify that his or
her Ordinary Shares be voted "for," "against" or "abstain" from voting with
respect to each of the proposals. If the enclosed proxy is properly executed,
duly returned to us in time for the General Meeting and not revoked, your
Ordinary Shares will be voted in accordance with the instructions contained
thereon. Where a signed proxy is returned, but no specific instructions are
indicated, your Ordinary Shares will be voted FOR each of the proposals.
<PAGE> 4
Proxies will not be counted as voting in respect of any matter as to which
abstinence is indicated, but abstentions will be counted as Ordinary Shares that
are present for purposes of determining whether a quorum is present. Nominees
who are members of the New York Stock Exchange, Inc. ("NYSE") and who, as
brokers, hold Ordinary Shares in "street name" for customers have, by NYSE
rules, the authority to vote on certain items in the absence of instructions
from their customers, the beneficial owners of the Ordinary Shares. Under these
rules, brokers that do not receive instructions are entitled to vote on the
first three proposals to be considered at the General Meeting. Ordinary Shares
held by such nominees for their beneficial owners will be counted for purposes
of determining whether a quorum is present.
Any shareholder who executes and returns a proxy may revoke it in writing
before it is voted at the General Meeting by: (i) filing with our Secretary, at
the address of our principal United States subsidiary, Amdocs, Inc. (at the
address that appears on the last page of this Proxy Statement), written notice
of such revocation bearing a later date than the proxy or a subsequent proxy
relating to the same Ordinary Shares, provided that such proxy or subsequent
proxy shall be deposited at such address at least forty-eight (48) hours before
the scheduled General Meeting or adjournment thereof, as the case may be; or
(ii) attending the General Meeting and voting in person (although attendance at
the General Meeting will not in and of itself constitute revocation of a proxy).
IMPORTANT
WHETHER OR NOT YOU ATTEND THE GENERAL MEETING, YOUR VOTE IS IMPORTANT.
ACCORDINGLY, YOU ARE ASKED TO SIGN AND RETURN THE ACCOMPANYING PROXY REGARDLESS
OF THE NUMBER OF ORDINARY SHARES YOU OWN. ORDINARY SHARES CAN BE VOTED AT THE
GENERAL MEETING ONLY IF THE HOLDER IS REPRESENTED BY PROXY OR IS PRESENT.
2
<PAGE> 5
PROPOSAL I
ELECTION OF DIRECTORS
The entire board of directors of Amdocs is comprised of eleven directors.
The eleven persons listed below are the nominees for election as directors at
the General Meeting. Each director elected at this General Meeting will serve
for a one-year term until the next annual general meeting of shareholders or
until his or her respective successor is elected and qualified or his or her
position is earlier vacated by resignation or otherwise.
Ordinary Shares represented by proxies returned duly executed will be
voted, unless otherwise specified, in favor of the eleven nominees for the board
of directors named below. If any (or all) of such persons should be unable to
serve, the persons named in the enclosed proxy will vote the shares covered
thereby for such substitute nominee (or nominees) as the board of directors may
select. The board of directors has no reason to believe that any such nominee
will be unable or unwilling to serve.
Set forth below are the names and ages of the nominees for director, the
principal occupations of each nominee currently and for at least the past five
years, and, where applicable, the year in which each became a director of
Amdocs.
<TABLE>
<CAPTION>
NAME AGE
- ---- ---
<S> <C> <C>
Bruce K. Anderson 59 Mr. Anderson has been Chief Executive Officer and Chairman
of the board of directors of Amdocs since September 1997.
Since August 1978, he has been a general partner of Welsh,
Carson, Anderson & Stowe ("WCAS"), an investment firm which
specializes in the acquisition of companies in the
information services, communications and health care
industries. Mr. Anderson served for nine years with
Automated Data Processing, Inc. ("ADP") until his
resignation as Executive Vice President and a director of
ADP, and President of ADP International, effective August
1978. Mr. Anderson serves on the board of several private
companies.
Adrian Gardner 37 Mr. Gardner has been a director of Amdocs since April 1998.
Mr. Gardner is an Executive Director of Lazard Brothers &
Co., Limited, based in London and works with technology and
telecommunications-related companies. Prior to joining
Lazard Brothers in 1989, Mr. Gardner qualified as a
chartered accountant with Price Waterhouse (now Price
Waterhouse Coopers). Mr. Gardner is a member of the
Institute of Chartered Accountants in England & Wales and a
member of The Securities Institute.
Stephen Hermer 38 Mr. Hermer has been a director of Amdocs since April 1998.
In 1998, Mr. Hermer joined the law firm of Olswang, based in
London, where he practices corporate and securities law.
Prior to that, he was a partner with the London law firm of
Frere Cholmeley Bischoff.
James S. Kahan 52 Mr. Kahan has been a director of Amdocs since April 1998.
Mr. Kahan has worked at SBC Communications Inc. ("SBC")
since 1983, and currently serves as its Senior Executive
Vice President-Corporate Development, a position he has held
since 1992. Prior to joining SBC, Mr. Kahan held various
positions at several telecommunications companies, including
Western Electric, Bell Laboratories, South Central Bell and
AT&T.
Paz Littman 43 Mr. Littman has been a director of Amdocs since September
1997. Since October 1996, he has served as President of
Aurum Management and Consulting Ltd., a privately held
company, which makes and manages investments for
shareholders of the Aurec Group. From 1991 to 1996, Mr.
Littman was an active partner with the law firm of Meitar,
Littman & Co.
</TABLE>
3
<PAGE> 6
<TABLE>
<CAPTION>
NAME AGE
- ---- ---
<S> <C> <C>
John T. McLennan 54 Mr. McLennan has been a director of Amdocs since November
1999. Mr. McLennan founded and has been the President of
Jenmark Consulting Inc. since 1997. From 1994 to 1997 Mr.
McLennan served as the President and Chief Executive Officer
of Bell Canada. Prior to that, he held various positions at
several telecommunications companies, including BCE Mobile
Communications and Cantel Inc. Mr. McLennan currently serves
on the board of directors of Architel Systems Corporation
and several other software/communication companies.
Robert A. Minicucci 47 Mr. Minicucci has been Chief Financial Officer and a
director of Amdocs since September 1997. He has been a
general partner of WCAS since 1993. From 1992 to 1993, Mr.
Minicucci served as Senior Vice President and Chief
Financial Officer of First Data Corporation, a provider of
information processing and related services for credit card
and other payment transactions. From 1991 to 1992, he served
as Senior Vice President and Treasurer of the American
Express Company. Mr. Minicucci served for twelve years with
Lehman Brothers (and its predecessors) until his resignation
as a Managing Director in 1991. He is also a director of
several private companies.
Avinoam Naor 51 Mr. Naor has been a director of Amdocs since January 1999
and is Chief Executive Officer of Amdocs Management Limited,
having overall coordination responsibility for the
operations and activities of our operating subsidiaries. Mr.
Naor was a member of the team that founded Amdocs in 1982
and initially served as a Senior Vice President. He has been
involved with software development for 28 years, working on
projects for the development of application and
infrastructure software for communications systems and
developing and marketing directory assistance systems. Mr.
Naor was also a member of the team that established the
computerized system for Golden Pages, the Israeli Yellow
Pages company.
Lawrence Perlman 61 Mr. Perlman has been a director of Amdocs since April 1998.
He has been Chairman of Ceridian Corporation since 1992, and
its Chief Executive Officer since 1990. Ceridian Corporation
is a provider of information services to employers to
administer various human resource functions, as well as
information services for the transportation and electronic
media markets. Mr. Perlman is a director and Chairman of
Seagate Technology, Inc., and a director of The Valspar
Corporation and Computer Network Technology Corporation. Mr.
Perlman has been a director of Ceridian since 1985.
Michael J. Price 42 Mr. Price has been a director of Amdocs since January 1998.
He is co-Chief Executive Officer of FirstMark Communications
International LLC, a broadband communications company in
Europe. Prior to that, he worked at Lazard Freres & Co.
L.L.C., starting in 1987, serving first as a Vice President
and then as a Managing Director, where he led its technology
and telecommunications group. He is also a director of
SpectraSite, a leading tower management company.
Urs Suter 41 Mr. Suter has been a director of Amdocs since May 1999 and
has been the managing partner of the law firm Suter
Attorneys at Law, in Zurich, Switzerland, since 1995. Prior
to that, he was a partner with Price Waterhouse (now Price
Waterhouse Coopers). He is also a director of several
private companies.
</TABLE>
4
<PAGE> 7
All directors hold office until the next annual meeting of our shareholders
or until their respective successors are duly elected and qualified or their
positions are earlier vacated by resignation or otherwise.
BOARD COMMITTEES
Our board of directors has formed three committees set forth below. Members
of each committee are appointed by the board of directors.
Executive Committee. The Executive Committee acts from time to time
instead of the full board of directors and has such responsibilities as may be
delegated to it by the board of directors. The current members of the Executive
Committee are Bruce K. Anderson, Adrian Gardner, Paz Littman, Robert A.
Minicucci and Avinoam Naor.
Audit Committee. The Audit Committee reviews, acts on and reports to the
board of directors with respect to various auditing and accounting matters,
including the selection of our auditors, the scope of the annual audits, fees to
be paid to the auditors, the performance of our independent auditors and our
accounting practices. The current members of the Audit Committee are Lawrence
Perlman and Adrian Gardner.
Compensation Committee. The Compensation Committee determines the salaries
and incentive compensation of the officers of Amdocs and our subsidiaries and
provides recommendations for the salaries and incentive compensation of other
employees and certain consultants. The Compensation Committee also administers
various compensation, stock and benefit plans of Amdocs. The current members of
the Compensation Committee are Bruce K. Anderson, Adrian Gardner, Paz Littman
and Robert A. Minicucci.
BOARD AND COMMITTEE MEETINGS
During the past fiscal year, the board of directors held six meetings and
took numerous other actions by unanimous written consent in lieu of formal
meetings. In addition, the Executive Committee held six meetings, the
Compensation Committee held four meetings and the Audit Committee held four
meetings in fiscal year 1999. The board of directors does not have a standing
nominating committee.
COMPENSATION OF DIRECTORS
We pay our non-employee directors either stock options or a cash payment
equal to (i) $30,000 per annum and (ii) $1,500 per meeting of the board of
directors and $500 per meeting of a committee of the board of directors. During
fiscal year 1999, no stock options were granted to directors. We reimburse all
of our directors for their reasonable travel expenses incurred in connection
with attending meetings of the board of directors or committees thereof.
It is proposed that the following Ordinary Resolution be adopted at the
General Meeting:
"RESOLVED, that Bruce K. Anderson, Adrian Gardner, Stephen Hermer, James S.
Kahan, John T. McLennan, Robert A. Minicucci, Avinoam Naor, Paz Littman,
Lawrence Perlman, Michael J. Price and Urs Suter are, and each hereby is,
elected to serve as a director of the Company, until the next annual general
meeting or until his respective successors are elected and qualified or his
position is earlier vacated by resignation or otherwise."
REQUIRED AFFIRMATIVE VOTE
The affirmative vote of a majority of the Ordinary Shares represented in
person or by proxy at the General Meeting is necessary for the approval of the
Ordinary Resolution to elect the nominees named above.
THE BOARD OF DIRECTORS RECOMMENDS THAT THE SHAREHOLDERS VOTE "FOR" THE
DIRECTOR NOMINEES NAMED ABOVE.
5
<PAGE> 8
SECURITY OWNERSHIP OF CERTAIN
BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth certain information with respect to the
beneficial ownership as of December 1, 1999 of (i) any person known to be the
beneficial owner of more than 10% of the outstanding Ordinary Shares and
non-voting Ordinary Shares (ii) all of our directors and executive officers as a
group.
<TABLE>
<CAPTION>
SHARES
BENEFICIALLY PERCENTAGE
NAME AND ADDRESS OWNED(1) OF OWNERSHIP(2)
---------------- ------------ ---------------
<S> <C> <C>
Welsh, Carson, Anderson & Stowe(3)(5)................... 40,511,803 19.7%
320 Park Avenue, Suite 2500
New York, New York 10022
SBC International Inc. (4).............................. 44,864,211 21.9%
175 E. Houston Street
San Antonio, Texas 78205-2233
Amdocs International Limited(5)(6)...................... 20,022,750 9.8%
Suite 5, Tower Hill House
Le Bordage, St. Peter Port
Guernsey GY1 3QT
The Channel Islands
All directors and executive officers as a group
(18 persons)(3)(4)(7)(8).............................. 124,539,359 60.7%
</TABLE>
- ---------------
(1) Unless otherwise indicated, the entities and individuals identified in this
table have sole voting and investment power with respect to all Ordinary
Shares and sole investment power with respect to all non-voting Ordinary
Shares shown as beneficially owned by them, subject to community property
laws, where applicable.
(2) The percentages shown are based on 181,040,634 Ordinary Shares and
24,210,073 non-voting Ordinary Shares outstanding on December 1, 1999. These
figures include 6,450,683 Ordinary Shares issued to stockholders of
International Telecommunication Data Systems, Inc. ("ITDS") pursuant to the
acquisition of ITDS that was completed on November 30, 1999.
(3) Includes 25,864,877 Ordinary Shares held by Welsh, Carson, Anderson & Stowe
VII, L.P., 7,417,770 Ordinary Shares held by Welsh, Carson, Anderson & Stowe
VI, L.P., 5,174,797 Ordinary Shares held by WCAS Capital Partners III, L.P.,
171,502 Ordinary Shares held by WCAS Information Partners, L.P. and
1,882,857 Ordinary Shares held by partners and others affiliated with WCAS.
Those partners are also partners of the sole general partner of each of the
foregoing limited partnerships. The partners of WCAS who are also directors
of Amdocs are Bruce K. Anderson (Chairman of the Board and Chief Executive
Officer of Amdocs) and Robert A. Minicucci (Chief Financial Officer of
Amdocs), and each may be deemed to be beneficial owners of the Ordinary
Shares held by WCAS. As a result of certain revenue and cash flow targets
for fiscal 1998 and fiscal 1999 having been met by us in full, pursuant to
an arrangement entered into in 1997, WCAS and certain of our other
shareholders transferred an aggregate of 15,198,040 shares to AIL, SBCI and
certain of our other shareholders with no change in the aggregate number of
Ordinary Shares outstanding. AIL and SBCI each received 6,154,138 Ordinary
Shares and the other shareholders received 2,889,764 Ordinary Shares.
(4) SBC International Inc. ("SBCI") is a wholly-owned subsidiary of SBC, a
company whose shares are publicly traded on the NYSE. The number of shares
shown as beneficially owned by SBCI is comprised of 20,654,138 Ordinary
Shares and 24,210,073 non-voting Ordinary Shares. SBCI is the only
shareholder of Amdocs that holds non-voting Ordinary Shares.
(5) In connection with our recapitalization effected as of May 20, 1998, in
advance of our initial public offering in June 1998, investment partnerships
affiliated with WCAS granted irrevocable proxies with respect to a total of
23,521,899 Ordinary Shares to a company which is the sole shareholder of AIL
and which is beneficially owned by Morris S. Kahn. The proxies granted by
the WCAS partnerships expire in May 2008, or sooner if at any time the WCAS
entities collectively own less than 10.0% of our outstanding
6
<PAGE> 9
capital shares. After giving effect to such proxies, AIL and its beneficial
shareholder will together have the right to vote 24.1% of our Ordinary
Shares, and WCAS will have the right to vote 11.4% of such shares.
(6) The number of shares shown as beneficially owned by AIL includes 10,000,000
Ordinary Shares that AIL may be required to deliver to the Amdocs Automatic
Common Exchange Security Trust (the "TRACES Trust") upon the exchange of
Automatic Common Exchange Securities that were issued and sold by the TRACES
Trust in June 1999. The exchange date for the Automatic Common Exchange
Securities will occur no earlier than June 11, 2002.
(7) Affiliates of WCAS, SBCI and AIL serve on our board of directors and,
accordingly, those affiliates may be deemed to be the beneficial owners of
the shares held by such entities.
(8) All of our key executive officers hold, directly and indirectly, economic
interest in approximately 27.8% of our outstanding shares (19.7% of which
are beneficially held by WCAS).
7
<PAGE> 10
PROPOSAL II
APPROVAL OF OUR CONSOLIDATED FINANCIAL STATEMENTS
FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 1999
Our Annual Report for the fiscal year ended September 30, 1999 is being
mailed to our shareholders together with this Proxy Statement. Our Consolidated
Financial Statements for the fiscal year ended September 30, 1999 are included
in such report. At the General Meeting, we will review the management's
discussion and analysis of results of operations and financial condition as
presented in our Annual Report for the fiscal year ended September 30, 1999 and
will answer appropriate questions related thereto.
It is proposed that the following Ordinary Resolution be adopted at the
General Meeting:
"RESOLVED, that the Consolidated Financial Statements for the Company for
the fiscal year ended September 30, 1999 be, and the same hereby are, approved."
REQUIRED AFFIRMATIVE VOTE
The affirmative vote of a majority of the Ordinary Shares represented in
person or by proxy at the General Meeting is necessary for the approval of the
Ordinary Resolution to approve the Consolidated Financial Statements.
THE BOARD OF DIRECTORS RECOMMENDS THAT THE SHAREHOLDERS VOTE "FOR" THE
APPROVAL OF OUR CONSOLIDATED FINANCIAL STATEMENTS.
8
<PAGE> 11
PROPOSAL III
APPROVAL OF INDEPENDENT AUDITORS
Upon recommendation of the Audit Committee, our board of directors has
selected and recommends to the shareholders that they (i) approve the firm of
Ernst & Young LLP to continue to serve as our independent auditors for the
fiscal year ending September 30, 2000, and until the next annual general
meeting, and (ii) authorize the board of directors to fix the remuneration of
such auditors. Ernst & Young LLP has audited Amdocs' books and accounts for the
fiscal year ended September 30, 1999 and has served as our independent auditors
since 1996. One or more representatives of Ernst & Young LLP are expected to be
present at the General Meeting, will have an opportunity to make a statement if
he or she so desires and will be available to respond to appropriate questions.
It is proposed that the following Ordinary Resolution be adopted at the
General Meeting:
"RESOLVED, that (i) the appointment of Ernst & Young LLP, as the Company's
independent auditors for the fiscal year ending September 30, 2000, and until
the Company's next annual general meeting be, and it hereby is, approved, and
(ii) the board of directors be, and it hereby is, authorized to fix the
remuneration of such independent auditors in accordance with the extent and
nature of their services."
REQUIRED AFFIRMATIVE VOTE
The affirmative vote of a majority of the Ordinary Shares represented in
person or by proxy at the General Meeting is necessary for the approval of Ernst
& Young LLP and the authorization of the board of directors to fix their
remuneration
THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" PROPOSAL III.
9
<PAGE> 12
PROPOSAL IV
AMENDMENT TO 1998 STOCK OPTION AND INCENTIVE PLAN
The board of directors has approved and recommends to the shareholders that
they approve a proposal to amend the 1998 Stock Option and Incentive Plan, as
amended (the "1998 Plan") to increase the number of Ordinary Shares available
for grant under the 1998 Plan from 6,600,000 Ordinary Shares to 13,300,000
Ordinary Shares, an increase of 6,700,000 Ordinary Shares. The text of the
proposed amendment to the 1998 Plan is set forth below.
Amdocs adopted the 1998 Plan in January 1998. The 1998 Plan provides for
the grant and/or award by Amdocs of options or restricted shares to the
officers, directors, employees or consultants of Amdocs or any of our
subsidiaries. In January 1999, the number of Ordinary Shares available under the
1998 Plan was increased from 4,100,000 to 6,600,000 Ordinary Shares.
The purpose of the 1998 Plan is to enable us to attract and retain
qualified personnel and to motivate such persons by providing them with an
equity participation in Amdocs. The 1998 Plan is administered by a committee
appointed by the Board and expires ten years after the date of its adoption.
As of December 15, 1999, options to purchase an aggregate of 6,398,600
Ordinary Shares have been granted and 201,400 Ordinary Shares remain available
for future grants.
The Ordinary Shares acquired upon exercise of an option and the restricted
shares that may be granted under the 1998 Plan will be subject to certain
restrictions on transfer, sale or hypothecation. Options will be exercisable and
restrictions on disposition of shares will lapse pursuant to the terms of the
individual agreements under which such options were granted or shares issued.
The board of directors has determined that the amendment to the 1998 Plan
is in the best interest of Amdocs and our shareholders. The proposed amendment
would provide additional Ordinary Shares for grants to our employees and others.
The board of directors believes that grants of options and/or awards are an
effective method to attract and to retain employees and others and that the
availability of Ordinary Shares for future grants under the 1998 Plan is
important to the business prospects and operations of Amdocs.
It is proposed that the following Ordinary Resolution be adopted at the
General Meeting:
"RESOLVED, that Section 5 of the Amdocs Limited 1998 Stock Option and
Incentive Plan, as amended as of June 17, 1998 and January 27, 1999 (the "1998
Plan"), is hereby amended by deleting the first sentence of the first paragraph
of said Section 5, and replacing it with the following:
"The maximum number of shares of Ordinary Shares reserved for grant of
awards under the Plan shall be 13,300,000."
REQUIRED AFFIRMATIVE VOTE
The affirmative vote of a majority of the Ordinary Shares represented in
person or by proxy at the General Meeting is necessary for the approval of the
Ordinary Resolution to approve the amendment to the 1998 Plan.
THE BOARD OF DIRECTORS BELIEVES THAT THE PROPOSAL IS IN THE BEST INTERESTS
OF AMDOCS AND ITS SHAREHOLDERS AND RECOMMENDS A VOTE "FOR" THE AMENDMENT TO THE
1998 PLAN.
10
<PAGE> 13
MISCELLANEOUS
ANNUAL REPORT TO SHAREHOLDERS
Our Annual Report for the fiscal year ended September 30, 1999, including
audited financial statements, accompanies this Proxy Statement.
ANNUAL REPORT ON FORM 20-F
We can provide without charge, at the written request of any beneficial
shareholder as of the Record Date, a copy of our Annual Report on Form 20-F,
including the financial statements, financial statement schedules and exhibits,
as filed with the Securities and Exchange Commission ("SEC"). Our Annual Report
on Form 20-F is also accessible to the general public via the Internet at the
SEC's web site located at http://www.sec.gov. Requests for copies of our Annual
Report on Form 20-F should be mailed to our principal United States subsidiary
at:
Amdocs, Inc.
1390 Timberlake Manor Parkway
Chesterfield, Missouri 63017
Fax: (314) 212-8358
E-mail: [email protected]
Attention: Mr. Thomas G. O'Brien
Secretary and Treasurer of Amdocs Limited
EXPENSES OF SOLICITATION
The cost of solicitation of proxies in the accompanying form will be borne
by Amdocs, including expenses in connection with preparing and mailing this
Proxy Statement. In addition to solicitation of proxies by mail, our directors,
officers and employees (who will receive no additional compensation therefor)
may solicit the return of proxies by telephone, facsimile or personal interview.
In addition, we have retained American Stock Transfer & Trust Company and W.F.
Doring & Co. to assist in the solicitation of proxies. We will also reimburse
brokerage houses and other custodians, nominees and fiduciaries for their
expenses in accordance with the regulations of the NYSE concerning the sending
of proxies and proxy materials to the beneficial owners of our Ordinary Shares.
BY ORDER OF THE BOARD OF DIRECTORS
/s/ Thomas G. O'Brien
Thomas G. O'Brien
Secretary
December 15, 1999
11
<PAGE> 14
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Amdocs Limited
/s/ THOMAS G. O'BRIEN
....................................
Thomas G. O'Brien
Treasurer and Secretary
Authorized U. S. Representative
Date: December 16, 1999
<PAGE> 15
AMDOCS LIMITED
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
The undersigned hereby appoints Bruce K. Anderson and Thomas G. O'Brien as
Proxies, each with the power to appoint his substitute, and hereby authorizes
them to represent and vote, as designated below, all Ordinary Shares of Amdocs
Limited (the "Company") held of record by the undersigned on December 1, 1999,
at the annual General Meeting of shareholders to be held on Janauary 26, 2000 or
any adjournment thereof.
(TO BE SIGNED ON REVERSE SIDE.)
<PAGE> 16
[ X ] PLEASE MARK YOUR VOTES AS IN THIS
EXAMPLE USING DARK INK ONLY.
NOMINEES: Bruce K. Anderson
WITHHOLD Adrian Gardner
FOR AUTHORITY Stephen Hermer
1. ELECTION OF James S. Kahan
DIRECTORS [ ] [ ] John T. McLennan
Robert A. Minicucci
Avinoam Naor
Paz Littman
Lawrence Perlman
Michael J. Price
Urs Suter
FOR. except vote withheld from the following nominees(s).
- ----------------------------------
FOR AGAINST ABSTAIN
2. APPROVAL OF CONSOLIDATED
FINANCIAL STATEMENTS FOR FISCAL
YEAR 1999. [ ] [ ] [ ]
3. APPROVAL OF ERNST & YOUNG LLP
AND AUTHORIZATION OF BOARD TO
FIX REMUNERATION. [ ] [ ] [ ]
4. APPROVAL OF AMENDMENT TO
STOCK OPTION AND INCENTIVE PLAN. [ ] [ ] [ ]
SIGNATURE(S) DATE
------------------------------------- --------------------
NOTE: Please sign exactly as name appears hereon. Joint owners should each sign.
When signing as attorney, executor, administrator, trustee or guardian,
please give full title as such.
